Clinical Trial Update: Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH) [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial (BACH) comparing randomized allocation versus patient-preference treatment with filgotinib or a TNF inhibitor in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)
• TNF inhibitor (class) (TNF inhibitor)

Snippet

Sponsor: R.Bos | Conditions: Rheumatoid Arthritis | Phase 4 | Status: RECRUITING